Infection Risk Associated With Colonization by Multidrug-Resistant Gram-Negative Bacteria: An Umbrella Review and Meta-analysis - Takeaways - MDSpire

Infection Risk Associated With Colonization by Multidrug-Resistant Gram-Negative Bacteria: An Umbrella Review and Meta-analysis

  • By

  • Edwin Wilbur Woodhouse

  • Majd Alsoubani

  • David J Roach

  • David B Flynn

  • Michael LaValley

  • Kristen Sheridan

  • David C Hooper

  • Vance G Fowler

  • Erin M Duffy

  • Trudy H Grossman

  • July 2, 2025

  • 0 min

Share

  • 1

    Infections from multidrug-resistant gram-negative bacteria (MDR-GNB) pose a significant global health threat, particularly from ESBL-E and CRE.

  • 2

    The pooled incidence of infection following colonization was found to be 22% for both ESBL-E and CRE in the reviewed studies.

  • 3

    The review highlighted a lack of high-quality findings on mortality and transmission related to MDR-GNB colonization.

  • 4

    Existing decolonization interventions have shown inconsistent benefits, indicating a need for new methods and accurate data on adverse outcomes.

  • 5

    The heterogeneity of included populations in the studies may limit the generalizability of the findings regarding infection risks.

Original Source(s)

Infection Risk Associated With Colonization by Multidrug-Resistant Gram-Negative Bacteria: An Umbrella Review and Meta-analysis

  • by Edwin Wilbur Woodhouse, Majd Alsoubani, David J Roach, David B Flynn, Michael LaValley, Kristen Sheridan, David C Hooper, Vance G Fowler, Erin M Duffy, Trudy H Grossman

  • July 2, 2025

Related Content

Comparison of the therapeutic performance of macrolide antibiotics on macrolide-resistant or macrolide-susceptible Mycoplasma pneumoniae pneumonia children

Amoxicillin-Clavulanate vs Amoxicillin for Sinusitis

Amoxicillin-clavulanate was not linked to lower treatment failure but was associated with a slightly higher risk of secondary infections compared with amoxicillin in adults with uncomplicated acute sinusitis.

Corallopyronin A exhibits potent activity against staphylococci including MRSA and isolates from prosthetic infections